Analysis of the TCGA-LIHC data revealed that in high-risk HCC, RAMP3 expression was downregulated, while the expression of G6PD, PLOD2 and SSRP1 were upregulated (Figure 7C). This evidence concerns the gene RAMP3 and hepatocellular carcinoma.